Analyze Diet
Journal of equine science2016; 26(4); 141-146; doi: 10.1294/jes.26.141

Quantification of horse plasma proteins altered by xylazine using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry.

Abstract: In the doping tests currently used in horse racing, prohibited substances or their metabolites are usually directly detected in urine or blood samples. However, despite their lasting pharmaceutical effects, some prohibited substances are rapidly eliminated from horse urine and blood, making them difficult to detect. Therefore, new indirect biomarkers for doping, such as plasma proteins that are increased by the prohibited substances, have recently attracted much attention. Here, a fluorogenic derivatization-liquid chromatography-tandem mass spectrometry (FD-LC-MS/MS) method was adopted for horse plasma proteomics analysis, in order to identify plasma proteins whose concentrations were altered in response to xylazine in Thoroughbred horses. Xylazine, which is rapidly absorbed and eliminated and has possibility of the change in the levels of plasma proteins, was selected as a model drug. Of the ten plasma proteins identified, four proteins, including three acute phase proteins (haptoglobin, ceruloplasmin, and α-2-macroglobulin-like), were significantly increased after xylazine administration. Therefore, our present approach might be useful in identifying indirect biomarkers of drug administration.
Publication Date: 2016-02-03 PubMed ID: 26858580PubMed Central: PMC4739145DOI: 10.1294/jes.26.141Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study uses advanced analytical methods to identify potential plasma proteins in horse blood that change in response to a specific drug called xylazine. This effort is aimed at improving the accuracy and sensitivity of drug doping tests in horse racing.

Background and Purpose

  • The research was conducted to address an ongoing challenge in horse racing, where prohibited substances or their metabolites are often hard to detect through conventional urine or blood tests due to their rapid elimination from the body.
  • The paper proposes the possibility of using altered plasma proteins as indirect biomarkers to detect the use of certain substances. This could provide more accurate results than direct testing methods.
  • Xylazine, a drug that is swiftly absorbed and eliminated from a horse’s body, was chosen as a model drug for testing this method. This suggests that the aim was to prove the concept with substances known to pose detection challenges.

Research Methodology

  • The researchers employed a fluorogenic derivatization-liquid chromatography-tandem mass spectrometry (FD-LC-MS/MS) method, a technique commonly used in bioanalysis, to study plasma proteins in horse blood.
  • The use of the FD-LC-MS/MS method enabled the researchers to analyze changes at the molecular level, specifically the change in plasma protein concentrations post xylazine administration.

Results and Insights

  • Out of ten plasma proteins identified during the FD-LC-MS/MS analysis, four proteins, including three acute phase proteins (haptoglobin, ceruloplasmin, and α-2-macroglobulin-like), showed a significant increase after xylazine administration.
  • This increase in specific plasma proteins post xylazine administration illustrates the potential of using altered plasma proteins as indirect biomarkers for drug administration. This approach could provide an essential tool for bolstering drug testing in horse racing.

Conclusion

  • The paper concluded that the technique used might help in identifying indirect biomarkers for drug administration. While the test was conducted with xylazine, the approach could potentially be applied to other substances used to dope horses in competitions.
  • The success of the research could lead to the development of more sensitive, effective antidoping controls, thereby ensuring fair competition and the welfare of horses in racing events.

Cite This Article

APA
Mori M, Ichibangase T, Yamashita S, Kijima-Suda I, Kawahara M, Imai K. (2016). Quantification of horse plasma proteins altered by xylazine using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry. J Equine Sci, 26(4), 141-146. https://doi.org/10.1294/jes.26.141

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 26
Issue: 4
Pages: 141-146

Researcher Affiliations

Mori, Miwako
  • Laboratory of Bio-analytical Chemistry, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan; Laboratory of Proteomics Analysis, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan; Laboratory of Racing Chemistry, Tochigi 320-0851, Japan.
Ichibangase, Tomoko
  • Laboratory of Proteomics Analysis, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan.
Yamashita, Shozo
  • Laboratory of Racing Chemistry, Tochigi 320-0851, Japan.
Kijima-Suda, Isao
  • Laboratory of Racing Chemistry, Tochigi 320-0851, Japan.
Kawahara, Masahiro
  • Laboratory of Bio-analytical Chemistry, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan.
Imai, Kazuhiro
  • Laboratory of Proteomics Analysis, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo 202-8585, Japan.

References

This article includes 23 references
  1. Ahmad Y, Sharma NK, Ahmad MF, Sharma M, Garg I, Bhargava K. Proteomic identification of novel differentiation plasma protein markers in hypobaric hypoxia-induced rat model.. PLoS One 2014;9(5):e98027.
  2. Amouzadeh HR, Qualls CW Jr, Wyckoff JH 3rd, Dzata GK, Sangiah S, Mauromoustakos A, Stein LE. Biochemical and morphological alterations in xylazine-induced pulmonary edema.. Toxicol Pathol 1993 Nov-Dec;21(6):562-71.
    pubmed: 8052803doi: 10.1177/019262339302100607google scholar: lookup
  3. Asamoto H, Ichibangase T, Uchikura K, Imai K. Application of an improved proteomics method, fluorogenic derivatization-liquid chromatography-tandem mass spectrometry, to differential analysis of proteins in small regions of mouse brain.. J Chromatogr A 2008 Oct 24;1208(1-2):147-55.
    pubmed: 18814880doi: 10.1016/j.chroma.2008.08.078google scholar: lookup
  4. Atwal OS, McDonell W, Staempfli H, Singh B, Minhas KJ. Evidence that halothane anaesthesia induces intracellular translocation of surface coat and Golgi response in equine pulmonary intravascular macrophages.. J Submicrosc Cytol Pathol 1994 Jul;26(3):369-86.
    pubmed: 8087800
  5. Barton C, Beck P, Kay R, Teale P, Roberts J. Multiplexed LC-MS/MS analysis of horse plasma proteins to study doping in sport.. Proteomics 2009 Jun;9(11):3058-65.
    pubmed: 19526555doi: 10.1002/pmic.200800737google scholar: lookup
  6. Björhall K, Miliotis T, Davidsson P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples.. Proteomics 2005 Jan;5(1):307-17.
    pubmed: 15619298doi: 10.1002/pmic.200400900google scholar: lookup
  7. Celly CS, Atwal OS, McDonell WN, Black WD. Histopathologic alterations induced in the lungs of sheep by use of alpha2-adrenergic receptor agonists.. Am J Vet Res 1999 Feb;60(2):154-61.
    pubmed: 10048544
  8. Eckersall PD, Lawson FP, Bence L, Waterston MM, Lang TL, Donachie W, Fontaine MC. Acute phase protein response in an experimental model of ovine caseous lymphadenitis.. BMC Vet Res 2007 Dec 19;3:35.
    pmc: PMC2235841pubmed: 18093286doi: 10.1186/1746-6148-3-35google scholar: lookup
  9. Füvesi J, Hanrieder J, Bencsik K, Rajda C, Kovács SK, Kaizer L, Beniczky S, Vécsei L, Bergquist J. Proteomic analysis of cerebrospinal fluid in a fulminant case of multiple sclerosis.. Int J Mol Sci 2012;13(6):7676-7693.
    pmc: PMC3397553pubmed: 22837721doi: 10.3390/ijms13067676google scholar: lookup
  10. Garcia-Villar R, Toutain PL, Alvinerie M, Ruckebusch Y. The pharmacokinetics of xylazine hydrochloride: an interspecific study.. J Vet Pharmacol Ther 1981 Jun;4(2):87-92.
  11. Ichibangase T, Moriya K, Koike K, Imai K. A proteomics method revealing disease-related proteins in livers of hepatitis-infected mouse model.. J Proteome Res 2007 Jul;6(7):2841-9.
    pubmed: 17559251doi: 10.1021/pr070094cgoogle scholar: lookup
  12. Ichibangase T, Imai K. Application of fluorogenic derivatization-liquid chromatography-tandem mass spectrometric proteome method to skeletal muscle proteins in fast Thoroughbred horses.. J Proteome Res 2009 Apr;8(4):2129-34.
    pubmed: 19714884doi: 10.1021/pr801004sgoogle scholar: lookup
  13. Ichibangase T, Moriya K, Koike K, Imai K. Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.. Biomed Chromatogr 2009 May;23(5):480-7.
    pubmed: 19039805doi: 10.1002/bmc.1139google scholar: lookup
  14. Ichibangase T, Sugawara Y, Yamabe A, Koshiyama A, Yoshimura A, Enomoto T, Imai K. An FD-LC-MS/MS proteomic strategy for revealing cellular protein networks: a conditional superoxide dismutase 1 knockout cells.. PLoS One 2012;7(9):e45483.
  15. Imai K, Ichibangase T, Saitoh R, Hoshikawa Y. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.. Biomed Chromatogr 2008 Nov;22(11):1304-14.
    pubmed: 18821527doi: 10.1002/bmc.1102google scholar: lookup
  16. Koshiyama A, Ichibangase T, Imai K. Comprehensive fluorogenic derivatization-liquid chromatography/tandem mass spectrometry proteomic analysis of colorectal cancer cell to identify biomarker candidate.. Biomed Chromatogr 2013 Apr;27(4):440-50.
    pubmed: 22991145doi: 10.1002/bmc.2811google scholar: lookup
  17. Munhoz TD, Faria JL, Vargas-Hérnandez G, Fagliari JJ, Santana AE, Machado RZ, Tinucci-Costa M. Experimental Ehrlichia canis infection changes acute-phase proteins.. Rev Bras Parasitol Vet 2012 Jul-Sep;21(3):206-12.
  18. Nakata K, Ichibangase T, Saitoh R, Ishigai M, Imai K. A trial proteomics fingerprint analysis of HepaRG cells by FD-LC-MS/MS.. Analyst 2015 Jan 7;140(1):71-3.
    pubmed: 25416652doi: 10.1039/c4an01434kgoogle scholar: lookup
  19. Okubo H, Miyanaga O, Nagano M, Ishibashi H, Kudo J, Ikuta T, Shibata K. Purification and immunological determination of alpha 2-macroglobulin in serum from injured rats.. Biochim Biophys Acta 1981 Apr 28;668(2):257-67.
    pubmed: 6164401doi: 10.1016/0005-2795(81)90033-7google scholar: lookup
  20. Ruiz-Colón K, Chavez-Arias C, Díaz-Alcalá JE, Martínez MA. Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature.. Forensic Sci Int 2014 Jul;240:1-8.
  21. Santonastaso A, Hardy J, Cohen N, Fajt V. Pharmacokinetics and pharmacodynamics of xylazine administered by the intravenous or intra-osseous route in adult horses.. J Vet Pharmacol Ther 2014 Dec;37(6):565-70.
    pubmed: 25066385doi: 10.1111/jvp.12136google scholar: lookup
  22. Sud R, Spengler RN, Nader ND, Ignatowski TA. Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory.. Eur J Pharmacol 2008 Jul 7;588(2-3):217-31.
  23. Wong JK, Wan TS. Doping control analyses in horseracing: a clinician's guide.. Vet J 2014 Apr;200(1):8-16.
    pubmed: 24485918doi: 10.1016/j.tvjl.2014.01.006google scholar: lookup

Citations

This article has been cited 1 times.
  1. Tozaki T, Kikuchi M, Kakoi H, Hirota KI, Mukai K, Aida H, Nakamura S, Nagata SI. Profiling of exercise-induced transcripts in the peripheral blood cells of Thoroughbred horses.. J Equine Sci 2016;27(4):157-164.
    doi: 10.1294/jes.27.157pubmed: 27974875google scholar: lookup